The Exchange has sought clarification from Wockhardt on January 04, 2017 with reference to news appeared in Business Standard dated January 04, 2017 quoting ‘US drug regulator issues warning to Wockhardts Ankleshwar plant’.
The above information is a part of company’s filings submitted to BSE.